跳至主要内容
临床试验/IRCT201506205283N12
IRCT201506205283N12已完成1 期

Comparing the effect of Aromatase inhibitor (Letrozol) + Cabergoline (Dostinex) and letrozol alone on uterine myoma regression

Vice chancellor for Research,Tabriz University Of Medical Sciences0 个研究点目标入组 76 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
76

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 45 years(—)
性别
Female

入选标准

  • women with Myoma larger than 4 cm and irregular menstrual cycle; Candidate for myomectomy or hysterectomy or treatment of infertility
  • Exclusion criteria: Age over 45 years; Uterine disease; Kidney disease; Liver disease; Antipsychotic drugs; Patients with history of use estrogen and progesterone in the last month; Patients with a history of drug treatment or surgery for uterine myoma and uterine bleeding

排除标准

  • 未提供

研究者

发起方
Vice chancellor for Research,Tabriz University Of Medical Sciences

相似试验